Magellan Asset Management LTD Johnson & Johnson Transaction History

Magellan Asset Management LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$126.95 - $142.14 $213,910 - $239,505	-1,685 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$131.15 - $144.24 $123,674 - $136,018	943 Added 127.09%	1,685 $235,000
Q1 2019 May 14, 2019	BUY	$125.72 - $139.79 $7,668 - $8,527	61 Added 8.96%	742 $104,000
Q3 2018 Nov 14, 2018	BUY	$121.58 - $142.88 $72,583 - $85,299	597 Added 710.71%	681 $94,000
Q1 2018 May 15, 2018	SELL	$125.1 - $148.14 $41,032 - $48,589	-328 Reduced 79.61%	84 $11,000
Q4 2017 Feb 14, 2018	BUY	$131.22 - $143.62 $11,153 - $12,207	85 Added 25.99%	412 $58,000
Q3 2017 Nov 13, 2017	BUY	$129.47 - $135.38 $42,336 - $44,269	327	327 $43,000

4,161

1.69B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $434B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Magellan Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Magellan Asset Management LTD with notifications on news.